You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

irAEs

Showing 1 - 25 of 216
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event Trial in Amiens (blood retriewal)

Recruiting
  • Immunotherapy
  • +5 more
  • blood retriewal
  • Amiens, Picardie, France
    CHU Amiens Picardie
Apr 3, 2023

Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

Completed
  • Immune Checkpoint Inhibitor
  • Endocrine Toxicity
    • Nanjing, Jiangsu, China
      First Affiliated Hospital, Nanjing Medical University
    Jan 6, 2023

    Multidimensional Aspects of QUAlity of Life After Cancer

    Recruiting
    • Solid Tumor
    • Hematologic Cancer
    • QoL & irAEs determinants
    • Pierre-Bénite, France
    • +4 more
    Nov 15, 2022

    LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • CT-scans extended
    • +3 more
    • Odense, Denmark
      Department of Oncology, Odense University Hospital
    May 17, 2022

    Multi-Centre, Prospective, Non-Interventional Study to

    Recruiting
    • Immune Related Adverse Events
    • PD-1
    • Sintilimab Injection
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Apr 7, 2021

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic

    Not yet recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Malignant Solid Neoplasm
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Dec 20, 2022

    Neurological Immune-related Adverse Events

    Recruiting
    • Neurological Disease
    • Analysis of biomarkers and their correlation with clinical characteristics and outcome
    • Bron, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Jul 28, 2023

    And Immuno-meDIated Adverse Events in Anti-cancer

    Not yet recruiting
    • Cancer
      • (no location specified)
      Jun 26, 2023

      Cancer, Cancer, Treatment-Related Trial in Chicago (ImmunOncoTool Condition)

      Completed
      • Cancer
      • Cancer, Treatment-Related
      • ImmunOncoTool Condition
      • Chicago, Illinois
        Northwestern University
      Apr 5, 2022

      Breast Cancer, Colon Cancer, Lung Cancer Trial in Tucson (Automated Telephone Symptom Management (ATMS) and Telephone

      Not yet recruiting
      • Breast Cancer
      • +4 more
      • Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C)
      • Active control comparator
      • Tucson, Arizona
        University of Arizona Cancer Center
      Feb 6, 2023

      sidE eFfects of ImmuNotherapy:Possible Clue to Optimize cancEr

      Recruiting
      • Melanoma
      • +4 more
      • Milano, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori
      Jan 10, 2022

      Immune Related Adverse Events, Colitis, Hepatitis Trial in Freiburg (ECP)

      Recruiting
      • Immune Related Adverse Events
      • +3 more
      • Freiburg, Baden-Württemberg, Germany
        Medical Center - University of Freiburg Albert-Ludwigs-Universit
      Jun 9, 2022

      Cancer, Immune System Disorder, Inflammatory Reaction Trial in Montreal

      Recruiting
      • Cancer
      • +3 more
        • Montreal, Quebec, Canada
          Jewish General Hospital
        Nov 30, 2021

        Malignancy, Immune System Diseases, Autoimmune Diseases Trial in Chapel Hill (Biospecimen Collection, Medical Chart Review,

        Recruiting
        • Malignancy
        • +2 more
        • Biospecimen Collection
        • +2 more
        • Chapel Hill, North Carolina
          Lineberger Comprehensive Cancer Center at University of North Ca
        Feb 11, 2022

        Blocking TNF to Potentiate ICI-dependent Immune Awakening in

        Recruiting
        • Melanoma
        • +2 more
          • Toulouse, France
            Institut Claudius Regaud
          May 25, 2023

          Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)

          Recruiting
          • Renal Cell Carcinoma
          • +3 more
          • Arterial Doppler for Flow Mediated Reserve measurement
          • Paris, France
            INstitut Mutualiste Montsouris
          Aug 29, 2023

          Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

          Not yet recruiting
          • Chronic Hepatitis b
          • Auckland, New Zealand
            New Zealand Clinical Research Auckland
          Jul 26, 2023

          Myocarditis Trial (Abatacept 250 MG)

          Not yet recruiting
          • Myocarditis
          • Abatacept 250 MG
          • (no location specified)
          Jul 5, 2022

          Immune-related Adverse Event, Dietary Habits Trial (Food box containing 30 different plants)

          Not yet recruiting
          • Immune-related Adverse Event
          • Dietary Habits
          • Food box containing 30 different plants
          • (no location specified)
          Apr 14, 2023

          Elderly Non-Small Cell Lung Cancer Patients

          Recruiting
          • Lung Cancer
          • Non-small Cell Lung Cancer
          • Questionnaires about symptoms
          • Cottingham, Hull, United Kingdom
            Castle Hill Hospital
          Mar 24, 2022

          Immune Checkpoint Inhibitors (AUTENTIC)

          Recruiting
          • Cancer
          • +2 more
          • Treatment with immune checkpoint inhibitors.
          • Blood tests.
          • Vitoria, Álava, Spain
            Hospital Universitario Araba
          Aug 27, 2021

          Cancer, Immune-related Adverse Event Trial in Durham (Medical chart review)

          Enrolling by invitation
          • Cancer
          • Immune-related Adverse Event
          • Medical chart review
          • Durham, North Carolina
            Duke University Medical Center
          Oct 20, 2023

          Melanoma, Lung Cancer Trial in Perugia (Systematic symptom assessment)

          Not yet recruiting
          • Melanoma
          • Lung Cancer
          • Systematic symptom assessment
          • Perugia, PG, Italy
            Oncologia Medica, Azienda Ospedaliera Universitaria
          Jun 9, 2021

          Nivolumab, Ipilimumab, and Chemotherapy in Non-small Cell Lung

          Not yet recruiting
          • Carcinoma, Non-Small-Cell Lung
            • Athens, Greece
              Local Institution - 0001
            Oct 26, 2022

            ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

            Completed
            • NSCLC
            • Immune checkpoint inhibitors plus angiogenesis inhibitors
            • Immune checkpoint inhibitors without angiogenesis inhibitors
            • Suzhou, Jiangsu, China
              The Affiliated Suzhou Hospital of Nanjing Medical University
            Jan 17, 2023